Aemetis (AMTX) Expected to Announce Earnings on Thursday

Aemetis (NASDAQ:AMTX) is expected to release its Q2 2026 results before the market opens on Thursday, August 6th. Analysts expect the company to post earnings of ($0.29) per share and revenue of $67.6870 million for the quarter. Individuals are encouraged to explore the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Thursday, August 6, 2026 at 2:00 PM ET.

Aemetis (NASDAQ:AMTX) last released its earnings results on Thursday, May 7th. The specialty chemicals company reported ($0.33) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by ($0.06). The company had revenue of $54.62 million during the quarter, compared to analyst estimates of $66.70 million. On average, analysts expect Aemetis to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Aemetis Stock Performance

Shares of NASDAQ AMTX opened at $1.52 on Tuesday. The stock has a 50 day moving average price of $1.86 and a 200 day moving average price of $2.06. Aemetis has a 52 week low of $1.30 and a 52 week high of $3.80. The stock has a market capitalization of $106.96 million, a PE ratio of -1.28 and a beta of 1.48.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on AMTX shares. Ascendiant Capital Markets upped their price objective on Aemetis from $21.00 to $22.00 and gave the stock a “buy” rating in a research note on Friday, May 22nd. Weiss Ratings restated a “sell (e+)” rating on shares of Aemetis in a report on Friday, July 17th. Finally, Wall Street Zen lowered shares of Aemetis from a “hold” rating to a “sell” rating in a research report on Saturday, June 6th. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Aemetis presently has an average rating of “Hold” and a consensus target price of $11.88.

Institutional Trading of Aemetis

Institutional investors and hedge funds have recently bought and sold shares of the business. Creative Planning acquired a new position in shares of Aemetis during the 2nd quarter worth approximately $30,000. Engineers Gate Manager LP acquired a new stake in Aemetis during the 2nd quarter valued at $42,000. Centiva Capital LP bought a new position in Aemetis during the third quarter worth $39,000. Virtu Financial LLC bought a new position in Aemetis during the fourth quarter worth $31,000. Finally, Tower Research Capital LLC TRC increased its holdings in shares of Aemetis by 206.7% in the second quarter. Tower Research Capital LLC TRC now owns 22,962 shares of the specialty chemicals company’s stock valued at $57,000 after purchasing an additional 15,474 shares during the last quarter. Institutional investors own 27.02% of the company’s stock.

Aemetis Company Profile

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.